CN104803838B - A kind of Herba Hedyotis Lanceae anthraquinone analog compound and preparation method thereof - Google Patents
A kind of Herba Hedyotis Lanceae anthraquinone analog compound and preparation method thereof Download PDFInfo
- Publication number
- CN104803838B CN104803838B CN201510242897.3A CN201510242897A CN104803838B CN 104803838 B CN104803838 B CN 104803838B CN 201510242897 A CN201510242897 A CN 201510242897A CN 104803838 B CN104803838 B CN 104803838B
- Authority
- CN
- China
- Prior art keywords
- extract
- chloroform
- herba hedyotis
- preparation
- column chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/34—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
- C07C46/10—Separation; Purification; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种剑叶耳草蒽醌类化合物及其制备方法,该化合物的结构式为:其制备方法包括以下步骤:(1)将剑叶耳草置于溶剂中浸提,浸提液减压浓缩,回收溶剂至无醇味;(2)将所得提取物加水稀释,再用极性由小到大的溶剂石油醚、氯仿、乙酸乙酯、正丁醇依次萃取分别得到相应的萃取液,分别将萃取液减压浓缩,收集氯仿部位干燥浸膏;(3)将所得氯仿部位干燥浸膏采用柱层析法进行分离纯化,获得所述剑叶耳草蒽醌类化合物。本发明的蒽醌类化合物为首次发现的化合物,丰富了现有化合物种类,具有良好的药理生理活性,具有抗肿瘤、止血、抗菌、泻下、利尿作用,且从用药吸收方面极性适宜,进一步推进剑叶耳草的开发和利用。The invention discloses anthraquinone compound of saponifera and a preparation method thereof. The structural formula of the compound is: The preparation method comprises the following steps: (1) extracting the saphophylla in a solvent, concentrating the extract under reduced pressure, recovering the solvent until it has no alcohol smell; (2) diluting the obtained extract with water, and then using polar From small to large solvents, petroleum ether, chloroform, ethyl acetate, and n-butanol, extract in sequence to obtain the corresponding extracts, respectively concentrate the extracts under reduced pressure, and collect the dried extracts of the chloroform parts; (3) dry the obtained chloroform parts The extract is separated and purified by column chromatography to obtain the anthraquinone compounds of the saponifera. The anthraquinone compound of the present invention is a compound discovered for the first time, which enriches the types of existing compounds, has good pharmacological and physiological activities, has antitumor, hemostatic, antibacterial, purgative, and diuretic effects, and has suitable polarity in terms of drug absorption. To further promote the development and utilization of saber-leaf ear grass.
Description
技术领域technical field
本发明属于药物化合物制备领域,特别涉及一种剑叶耳草蒽醌类化合物及其制备方法。The invention belongs to the field of preparation of pharmaceutical compounds, and in particular relates to anthraquinone compound of genus saponifera and a preparation method thereof.
背景技术Background technique
剑叶耳草(Hedyotis caudatifolia Merr.et Metcalf),为茜草科耳草属植物剑叶耳草的全草,别名少年红、长尾耳草、千年茶、产后茶、痨病草,是一种广西民间草药,有止咳化痰,健脾消积等功效,常用于治疗支气管哮喘、支气管炎、肺痨咯血、小儿疳积、跌打肿痛、外伤出血等。Sword-leaf eargrass (Hedyotis caudatifolia Merr.et Metcalf), is the whole herb of Rubiaceae eargrass plant Hedyotis caudatifolia Merr.et Metcalf, also known as juvenile red, long-tailed ear grass, millennium tea, postpartum tea, tuberculosis grass, is a Guangxi Folk herbal medicine has the functions of relieving cough and reducing phlegm, invigorating the spleen and eliminating accumulation, etc.
剑叶耳草目前涉及到的研究主要有根、茎、叶显微结构的研究、挥发油成分的GC-MS分析和其提取物对肝脏的保护作用。民间常有老中医用于治疗乙型肝炎,效果显著。与其在民间广泛的使用相比,目前国内外对剑叶耳草的研究极少,对剑叶耳草化学成分的研究除挥发油成分以外几乎空白,尤其是对其有效成分的研究存在很多空白,这样的现状大大影响了剑叶耳草的合理推广及使用,因此,对剑叶耳草有效成分进行系统研究显得极为重要,不仅可以为阐明剑叶耳草药效作用机制提供物质基础,促进剑叶耳草资源的合理开发及利用,同时对推动剑叶耳草作为中医药走向规范化、国际化提供了物质依据,并对完善剑叶耳草的相关理论及推动中医药现代化有重要意义。Currently, the researches involved in sword-leaf eargrass mainly include research on the microstructure of roots, stems and leaves, GC-MS analysis of volatile oil components and the protective effect of its extracts on the liver. Folks often have old Chinese medicine for the treatment of hepatitis B, and the effect is remarkable. Compared with its widespread use in the folk, there are very few researches on C. saponifera at home and abroad at present. The research on the chemical constituents of C. saponifera is almost blank except for the volatile oil components. This status quo has greatly affected the rational promotion and use of P. saponifera. Therefore, it is extremely important to carry out systematic research on the active ingredients of P. raptoria. The rational development and utilization of Auricularia fragrans resources provide a material basis for promoting the standardization and internationalization of Auricularia fragrans as a traditional Chinese medicine.
蒽醌类化合物具有广泛的生物活性,蒽醌类化合物大多具有一定的抗菌活性及致泻作用,某些蒽醌类成分还具有止血、抗肿瘤、抗骨质疏松、利尿等作用。Anthraquinone compounds have a wide range of biological activities. Most of the anthraquinone compounds have certain antibacterial activity and laxative effect. Some anthraquinone compounds also have hemostatic, anti-tumor, anti-osteoporosis, diuretic and other effects.
发明内容Contents of the invention
本发明要解决的技术问题是提供一种剑叶耳草蒽醌类化合物及其制备方法,该蒽醌类化合物为首次发现的化合物,具有良好的药理生理活性,具有抗肿瘤、止血、抗菌、泻下、利尿作用,且从用药吸收方面极性适宜,进一步推进剑叶耳草的开发和利用。The technical problem to be solved by the present invention is to provide a kind of anthraquinone compound and its preparation method. The anthraquinone compound is a compound discovered for the first time, has good pharmacological and physiological activities, and has antitumor, hemostatic, antibacterial, It has purgatory and diuretic effects, and has suitable polarity in terms of drug absorption, which further promotes the development and utilization of phobia.
为解决上述技术问题,本发明采用如下技术方案:In order to solve the problems of the technologies described above, the present invention adopts the following technical solutions:
一种剑叶耳草蒽醌类化合物,结构式为:A saponifera anthraquinone compound, the structural formula is:
所述的剑叶耳草蒽醌类化合物的制备方法,包括以下步骤:The preparation method of the described saphophylla anthraquinone compound comprises the following steps:
(1)将剑叶耳草粉碎,置于溶剂中浸提,溶剂重量为剑叶耳草重量的4~12倍,溶剂为水、有机溶剂中的一种或两种混合物,有机溶剂为甲醇、乙醇、丙酮、乙腈、氯仿、丙酮、石油醚和乙酸乙酯中的一种或两种以上混合;将所得浸提液减压浓缩,回收溶剂至无醇味,得提取物,将所得浸提液减压浓缩,回收溶剂至无醇味,得提取物;(1) Pulverize the saphophylla, place it in a solvent for extraction, the weight of the solvent is 4 to 12 times the weight of the saphophylla, the solvent is one or a mixture of water and an organic solvent, and the organic solvent is methanol , ethanol, acetone, acetonitrile, chloroform, acetone, petroleum ether and ethyl acetate, or one or more of them are mixed; Concentrate the extract under reduced pressure, recover the solvent until it has no alcohol smell, and obtain the extract;
(2)将步骤(1)所得提取物加水稀释为浓度为0.02~1g/ml的水溶液,再用极性由小到大的溶剂石油醚、氯仿、乙酸乙酯、正丁醇依次萃取分别得到相应的萃取液,分别将萃取液减压浓缩,收集氯仿部位干燥浸膏;(2) Dilute the extract obtained in step (1) with water to an aqueous solution with a concentration of 0.02 to 1 g/ml, and then extract successively with solvents petroleum ether, chloroform, ethyl acetate, and n-butanol with increasing polarity to obtain For the corresponding extracts, respectively concentrate the extracts under reduced pressure, and collect the dry extracts from the chloroform parts;
(3)将步骤(2)所得氯仿部位干燥浸膏采用柱层析法进行分离纯化,获得所述剑叶耳草蒽醌类化合物;所述柱层析法的担体为硅胶、氧化铝、聚酰胺或十八烷基硅烷,洗脱液为体积比为100:1~5:1的氯仿/丙酮混合液或体积比为200:1~6:1的氯仿/甲醇混合液。(3) Separating and purifying the dried extract from the chloroform part obtained in step (2) by column chromatography to obtain the anthraquinone compound of the genus flavinus; the support of the column chromatography is silica gel, aluminum oxide, poly Amide or octadecylsilane, the eluent is a chloroform/acetone mixture with a volume ratio of 100:1 to 5:1 or a chloroform/methanol mixture with a volume ratio of 200:1 to 6:1.
所述步骤(1)的浸提为:分别以体积浓度为95%的乙醇、体积浓度为80%的乙醇、体积浓度为60%的乙醇、体积浓度为40%的乙醇和水作为溶剂对剑叶耳草进行渗漉提取,剑叶耳草和每一溶剂的质量比均为1:8,合并提取液,将所得提取液减压浓缩,回收溶剂至无醇味,得提取物。The leaching of described step (1) is: the ethanol that is 95% by volume concentration, the ethanol that volume concentration is 80%, the ethanol that volume concentration is 60%, the ethanol that volume concentration is 40% and water are used as solvent to Fenugreek is subjected to percolation extraction, the mass ratio of Fenugreek to each solvent is 1:8, the extracts are combined, the obtained extracts are concentrated under reduced pressure, and the solvent is recovered until there is no alcohol smell to obtain the extract.
所述步骤(3)的柱层析法采用正相硅胶柱层析。The column chromatography of the step (3) adopts normal phase silica gel column chromatography.
还包括将步骤(3)经正相硅胶柱层析获得的目标流份利用Sephadex LH-20、反相硅胶柱层析或高效液相色谱进行纯化,获得所述剑叶耳草蒽醌类化合物。It also includes purifying the target fraction obtained through normal phase silica gel column chromatography in step (3) using Sephadex LH-20, reversed phase silica gel column chromatography or high performance liquid chromatography, to obtain the saponifera anthraquinone compound .
所述硅胶的粒度为200~300目。The particle size of the silica gel is 200-300 mesh.
所述步骤(3)还包括:将步骤(2)所得氯仿部位干燥浸膏进行柱色谱分离,然后使用氯仿/丙酮混合液梯度洗脱,氯仿/丙酮混合液中氯仿/丙酮的体积比依次为:100:1→80:1→50:1→20:1→10:1→5:1→2:1→1:1;收集的洗脱流份为氯仿/丙酮体积比为50:1的混合液洗脱下来的溶液,再经薄层色谱检测显色,合并相同流份,减压浓缩和干燥,得到暗绿色羽毛状结晶;再经硅胶柱层析分离,硅胶柱层析中采用体积比为5:1~1:2的氯仿/甲醇梯度洗脱,得到黄绿色羽毛状结晶,再经Sephadex LH-20柱色谱反复纯化,然后用体积比为1:1的氯仿/甲醇混合液洗脱,得到淡绿色羽毛状结晶,即为所述剑叶耳草蒽醌类化合物。The step (3) also includes: performing column chromatographic separation on the dry extract of the chloroform part obtained in step (2), and then using the gradient elution of the chloroform/acetone mixed solution, and the volume ratio of the chloroform/acetone in the chloroform/acetone mixed solution is sequentially : 100:1→80:1→50:1→20:1→10:1→5:1→2:1→1:1; the collected elution fraction is the chloroform/acetone volume ratio of 50:1 The solution eluted from the mixed solution was detected by thin-layer chromatography for color development, and the same fractions were combined, concentrated and dried under reduced pressure to obtain dark green feathery crystals; then separated by silica gel column chromatography, volume Gradient elution with chloroform/methanol at a ratio of 5:1 to 1:2 yielded yellow-green feathery crystals, which were repeatedly purified by Sephadex LH-20 column chromatography, and then washed with a mixture of chloroform/methanol at a volume ratio of 1:1 The light green feathery crystals are obtained, which are the said saponiferium anthraquinone compounds.
所述柱色谱的吸附剂用100~200目硅胶。The adsorbent of the column chromatography is 100-200 mesh silica gel.
所述剑叶耳草采用剑叶耳草植株的全草。The whole herb of the saphophyllum plant is used for the saphophyllium.
与现有技术相比,本发明的有益效果为:Compared with prior art, the beneficial effect of the present invention is:
本发明剑叶耳草蒽醌类化合物为首次发现的化合物,丰富了现有化合物种类。该蒽醌类化合物具有良好的药理生理活性,具有抗肿瘤、止血、抗菌、泻下、利尿作用,且从用药吸收方面极性适宜,进一步推进剑叶耳草的开发和利用。The anthraquinone compound of the saponifera of the present invention is a compound discovered for the first time, which enriches the types of existing compounds. The anthraquinone compound has good pharmacological and physiological activities, has anti-tumor, hemostatic, antibacterial, purgatory and diuretic effects, and has suitable polarity in terms of drug absorption, and further promotes the development and utilization of the saber ear grass.
附图说明Description of drawings
图1为所述剑叶耳草蒽醌的质谱;Fig. 1 is the mass spectrometry of described saponifera anthraquinone;
图2为所述剑叶耳草蒽醌的高分辨质谱;Fig. 2 is the high-resolution mass spectrum of the anthraquinone of the saponifera;
图3为所述剑叶耳草蒽醌的400MHz 1H-NMR谱;Fig. 3 is the 400MHz 1 H-NMR spectrum of the anthraquinone of the saponifera;
图4为所述剑叶耳草蒽醌的600MHz 1H-NMR谱;Fig. 4 is the 600MHz 1 H-NMR spectrum of the anthraquinone of the saponifera;
图5为所述剑叶耳草蒽醌的100MHz 13C-NMR和DEPT谱;Fig. 5 is the 100MHz 13 C-NMR and DEPT spectra of the flavana anthraquinone;
图6为所述剑叶耳草蒽醌的150MHz 13C-NMR谱;Fig. 6 is the 150MHz 13 C-NMR spectrum of the anthraquinone of the saponifera;
图7为所述剑叶耳草蒽醌的HSQC谱;Fig. 7 is the HSQC spectrum of described saponifera anthraquinone;
图8为所述剑叶耳草蒽醌的1H-1H COSY谱;Fig. 8 is the 1 H- 1 H COZY spectrum of the anthraquinone of the saponifera;
图9为所述剑叶耳草蒽醌的HMBC谱;Fig. 9 is the HMBC spectrum of the anthraquinone of the saponifera;
图10为化合物的结构式和关键相关关系。Figure 10 shows the structural formulas and key correlations of the compounds.
具体实施方式detailed description
以下结合附图及实施例对本发明作进一步详细说明,但不构成对本发明权利保护范围的限制。The present invention will be described in further detail below in conjunction with the accompanying drawings and embodiments, but this does not constitute a limitation to the protection scope of the present invention.
实施例1Example 1
(1)所用的剑叶耳草样品,采于广西金秀瑶族自治县。取剑叶耳草样品30kg,粉碎后分别以体积浓度分别为95%、80%、60%、40%的乙醇和水作为溶剂将剑叶耳草渗漉提取,剑叶耳草和每一溶剂的质量比均为1:8,合并提取液,合并提取液,减压浓缩,回收溶剂至无醇味,得总提取物。(1) The samples of Aurantium saponifera used were collected in Jinxiu Yao Autonomous County, Guangxi. Get 30kg of saponifera samples, pulverize them respectively with ethanol and water with volume concentrations of 95%, 80%, 60%, and 40% as solvents to extract saphophyllium by percolation, saphophylla and each solvent The mass ratios of both are 1:8, the combined extracts are concentrated under reduced pressure, the solvent is recovered until there is no alcohol smell, and the total extract is obtained.
(2)总提取物加水混悬至浓度为0.02~1g/ml,再依次用60~90℃石油醚、氯仿、乙酸乙酯、正丁醇进行萃取,分别减压浓缩回收溶剂,分别得到石油醚部位干燥浸膏、氯仿部位干燥浸膏、乙酸乙酯部位干燥浸膏和正丁醇部位干燥浸膏。(2) Add water and suspend the total extract to a concentration of 0.02-1g/ml, then sequentially extract with petroleum ether, chloroform, ethyl acetate, and n-butanol at 60-90°C, concentrate and recover the solvent under reduced pressure, respectively, and obtain petroleum Ether part dry extract, chloroform part dry extract, ethyl acetate part dry extract and n-butanol part dry extract.
(3)将氯仿部位干燥浸膏用100~200目硅胶进行柱色谱分离,使用氯仿/丙酮混合液梯度洗脱,氯仿/丙酮混合液中氯仿/丙酮的体积比依次为:100:1→80:1→50:1→20:1→10:1→5:1→2:1→1:1;收集的洗脱流份为氯仿/丙酮体积比为50:1的混合液洗脱下来的溶液,经薄层色谱检测显色,合并相同流份,减压浓缩、干燥,得到暗绿色羽毛状结晶。(3) Use 100-200 mesh silica gel to separate the dry extract from the chloroform part by column chromatography, and use the chloroform/acetone mixed solution for gradient elution. The volume ratio of chloroform/acetone in the chloroform/acetone mixed solution is: 100:1→80 :1→50:1→20:1→10:1→5:1→2:1→1:1; the collected elution fraction is eluted from the mixture of chloroform/acetone with a volume ratio of 50:1 The color of the solution was detected by thin-layer chromatography, and the same fractions were combined, concentrated under reduced pressure, and dried to obtain dark green feathery crystals.
(4)暗绿色羽毛状结晶再经200~300目硅胶柱层析分离,硅胶柱层析中采用体积比为5:1~1:2的氯仿/甲醇梯度洗脱,得到黄绿色羽毛状结晶,再经Sephadex LH-20柱色谱反复纯化,然后用体积比为1:1的氯仿/甲醇混合液洗脱,得到淡绿色羽毛状结晶,即为所述剑叶耳草蒽醌类化合物。(4) The dark green feathery crystals were separated by 200-300 mesh silica gel column chromatography, and the silica gel column chromatography was eluted with a gradient of chloroform/methanol with a volume ratio of 5:1-1:2 to obtain yellow-green feathery crystals , and then repeatedly purified by Sephadex LH-20 column chromatography, and then eluted with a chloroform/methanol mixture with a volume ratio of 1:1 to obtain light green feathery crystals, which are the saphophyllium anthraquinone compounds.
实施例2:Example 2:
(1)将剑叶耳草全草粉碎,置于溶剂中浸提,溶剂重量为剑叶耳草重量的4~12倍,溶剂为甲醇;将所得浸提液减压浓缩,回收溶剂至无醇味,得提取物,取少量提取物完全干燥,获得提取物干膏,并称重,根据所得的提取物干膏质量计算总的提取物净重;(1) Pulverize the whole herb of C. saponifera and place it in a solvent for extraction. The weight of the solvent is 4 to 12 times the weight of C. fragrans, and the solvent is methanol; Alcoholic taste, to obtain the extract, take a small amount of extract and dry it completely to obtain a dry paste of the extract, and weigh it, and calculate the net weight of the total extract according to the quality of the obtained dry paste of the extract;
(2)将步骤(1)所得提取物按实际净重加水稀释至浓度为0.02~1g/ml的水溶液,再用极性由小到大的溶剂石油醚、氯仿、乙酸乙酯、正丁醇依次萃取分别得到相应的萃取液,分别将萃取液减压浓缩,收集氯仿部位干燥浸膏;(2) Dilute the extract obtained in step (1) with water to a concentration of 0.02 to 1 g/ml according to the actual net weight, and then use the solvent petroleum ether, chloroform, ethyl acetate, and n-butanol in sequence from small to large polarity The corresponding extracts were obtained by extraction, the extracts were respectively concentrated under reduced pressure, and the dry extracts were collected from the chloroform parts;
(3)将步骤(2)所得氯仿部位干燥浸膏采用正相硅胶柱层析进行分离纯化,硅胶的粒度为200~300目,获得所述剑叶耳草蒽醌类化合物;所述正相硅胶柱层析的洗脱液为体积比为100:1~5:1的氯仿/丙酮混合液或体积比为200:1~6:1的氯仿/甲醇混合液。(3) Separating and purifying the dry extract from the chloroform part obtained in step (2) by normal phase silica gel column chromatography, the particle size of the silica gel is 200 to 300 meshes, and obtaining the anthraquinone compound of the saponifera; the normal phase The eluent of silica gel column chromatography is a chloroform/acetone mixture with a volume ratio of 100:1 to 5:1 or a chloroform/methanol mixture with a volume ratio of 200:1 to 6:1.
剑叶耳草蒽醌类化合物的结构鉴定:Structural identification of anthraquinone compounds from P.
所述的化合物为淡绿色羽毛状结晶,易溶于氯仿。TLC检识,三种不同展开系统中展开,碘蒸气显色,显示黄色单斑,结果如下:体积比1:1的石油醚-乙酸乙酯,Rf=0.28;体积比5:1的氯仿-丙酮,Rf=0.53;体积比10:1的氯仿-甲醇,Rf=0.64。The compound is light green feathery crystal, easily soluble in chloroform. TLC detection, development in three different development systems, iodine vapor color development, showing a yellow single spot, the results are as follows: petroleum ether-ethyl acetate with a volume ratio of 1:1, R f =0.28; chloroform with a volume ratio of 5:1 - acetone, R f =0.53; chloroform-methanol in volume ratio 10:1, R f =0.64.
质谱如图1所示,高分辨质谱如图2所示,EI-MS m/z(%):314(M+,100),299,281,253,239,225;HR-EI-MS m/z:314.0791[M]+,高分辨质谱计算分子式为C17H14O6.同时由13C-NMR及DEPT谱数据,也可推测分子式为C17H14O6,不饱和度为8。The mass spectrum is shown in Figure 1, and the high-resolution mass spectrum is shown in Figure 2, EI-MS m/z(%): 314(M + ,100), 299,281,253,239,225; HR-EI-MS m/z: 314.0791[M] + , the molecular formula calculated by high-resolution mass spectrometry is C 17 H 14 O 6 . At the same time, from the 13 C-NMR and DEPT spectrum data, it can also be speculated that the molecular formula is C 17 H 14 O 6 and the degree of unsaturation is 8.
1H-NMR和13C-NMR谱用TMS做内标,溶剂为CDCl3。化合物的1H-NMR(400MHz)如图3所示,1H-NMR(600MHz)如图4所示,13C-NMR和DEPT(100MHz)如图5所示,13C-NMR(150MHz)如图6所示,HSQC如图7所示,1H-1H COSY如图8所示,HMBC如图9所示。TMS was used as internal standard for 1 H-NMR and 13 C-NMR spectra, and the solvent was CDCl 3 . 1 H-NMR (400MHz) of the compound is shown in Figure 3, 1 H-NMR (600MHz) is shown in Figure 4, 13 C-NMR and DEPT (100MHz) are shown in Figure 5, 13 C-NMR (150MHz) As shown in Figure 6, HSQC is shown in Figure 7, 1 H- 1 H COZY is shown in Figure 8, and HMBC is shown in Figure 9.
通过图1-9解析得出如图10所示的化合物结构式和关键相关关系。Through the analysis of Figures 1-9, the structural formulas and key correlations of the compounds shown in Figure 10 are obtained.
其1H-NMR、13C-NMR数据归属及二维谱相关关系如表1。Its 1 H-NMR, 13 C-NMR data assignment and two-dimensional spectral correlation are shown in Table 1.
表1剑叶耳草蒽醌类化合物的一维和二维核磁共振谱(溶剂CDCl3,内标TMS,600/150MHz及400/100MHz)Table 1 The one-dimensional and two-dimensional NMR spectra of anthraquinone compounds in Auranthus fragrans (solvent CDCl 3 , internal standard TMS, 600/150MHz and 400/100MHz)
注:*序号见图10所示;**仅DEPT为100MHz,其他均为600/150MHz;***通过HSQC谱确定1H信号与13C信号的对应关系;****括号中表示二键相关关系。Note: * The serial number is shown in Figure 10; ** Only DEPT is 100MHz, and others are 600/150MHz; ***Confirm the corresponding relationship between 1 H signal and 13 C signal through HSQC spectrum; **** Brackets indicate two key relationship.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510242897.3A CN104803838B (en) | 2015-05-13 | 2015-05-13 | A kind of Herba Hedyotis Lanceae anthraquinone analog compound and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510242897.3A CN104803838B (en) | 2015-05-13 | 2015-05-13 | A kind of Herba Hedyotis Lanceae anthraquinone analog compound and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104803838A CN104803838A (en) | 2015-07-29 |
| CN104803838B true CN104803838B (en) | 2016-08-17 |
Family
ID=53689091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510242897.3A Expired - Fee Related CN104803838B (en) | 2015-05-13 | 2015-05-13 | A kind of Herba Hedyotis Lanceae anthraquinone analog compound and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104803838B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106676556A (en) * | 2016-12-26 | 2017-05-17 | 广西中医药大学 | Preparation method for natural rust remover |
| CN108003002B (en) * | 2017-11-27 | 2021-03-30 | 浙江工商大学 | Emodin type anthraquinone Hedyanthraquinone A and preparation method and application thereof |
| CN110438177A (en) * | 2019-08-12 | 2019-11-12 | 三原利华生物技术有限公司 | A method of ceramide is prepared from apple juicing pomace |
-
2015
- 2015-05-13 CN CN201510242897.3A patent/CN104803838B/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| "A new anthraquinone from Cassia Renigera";Meena Rani et al;《Indian Journal of Heterocyclic Chemistry》;199712;第7卷;161-162,第161页结构式I * |
| "two new anthraquinones from hemerocallis fulva";Yu-Ling Huang;《the chinese pharmaceutical journal》;200302;第55卷(第1期);83-86 * |
| "剑叶耳草挥发油的GC-MS分析";潘为高等;《中国实验方剂学杂志》;201208;第18卷(第15期);130-134 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104803838A (en) | 2015-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103145677B (en) | Method for separating active ingredients from aquilaria sinensis lamina by utilizing high-speed countercurrent chromatography | |
| CN103550273A (en) | Method for extracting low-pesticide-residue ginsenoside from ginsengs | |
| CN103483402A (en) | Method for purifying and preparing stevioside and rebaudioside-A | |
| CN108707133B (en) | Lignans compound, and method and application for extracting and separating lignans compound from eagle tea | |
| CN101100475A (en) | Method for separating and preparing glucoraphanin from broccoli seeds | |
| CN104803838B (en) | A kind of Herba Hedyotis Lanceae anthraquinone analog compound and preparation method thereof | |
| CN104000840A (en) | Preparation method of extractive containing gastrodin and gastrodia elata polysaccharide | |
| CN105330710B (en) | A method for simultaneously extracting three iridoid glycosides chemical reference substances from Ligustrum lucidum | |
| CN105153071A (en) | Terpenoid preparation method | |
| CN103086967B (en) | Alkaloid having type 1 skeleton in Nigellaglandulifera Freyn grass seeds, and its preparation method | |
| CN105434539A (en) | Composition of lotus flavones | |
| CN105481754A (en) | Indole alkaloid type compound and preparation method and application thereof | |
| CN101735050B (en) | Blumeabalsamifera extract as well as extracting method and application thereof | |
| CN110025677B (en) | Preparation method of rhubarb extract | |
| CN107513049A (en) | Euphorbia diterpenoids moleplant seed diterpene A preparation method and application | |
| CN101575356A (en) | Method for extracting and purifying 7-xylose-10-deacetyl paclitaxel from taxus cuspidata | |
| CN106668234B (en) | Rose extraction and purification process for total flavonoids | |
| CN107074798B (en) | Method for extracting phytoxin from rhodiola rosea | |
| CN105061455B (en) | It is a kind of can massively separating high purity gambogicacid and Neo-garcinolic acid simultaneously method | |
| CN108101952A (en) | A kind of preparation method of ginsenoside Re and Rd | |
| CN107343897B (en) | A kind of method for separating effective parts group from gardenia rhubarb soup | |
| CN1307193C (en) | Process of preparing total iridoid glycoside with cape jasmine fruit | |
| CN105902592A (en) | Method for extracting sesquiterpene components from wingedtooth laggera herb | |
| CN104983789A (en) | Separating method for fine active dracocephalum heterophyllum component and application of fine active dracocephalum heterophyllum component | |
| CN104292081B (en) | A kind of method extracting batatasins from plant Rhizoma Dioscoreae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |